Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a real-world retrospective observational study.
CONCLUSION: These results suggest that real-world outcomes in this community oncology setting improved with the introduction of immuno-oncology therapies. However, clinical benefits are limited in certain subgroups and tend to be reduced compared with clinical trial observations.
PMID: 33263865 [PubMed - as supplied by publisher]
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Nadler E, Arondekar B, Aguilar KM, Zhou J, Chang J, Zhang X, Pawar V Tags: J Cancer Res Clin Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Electronic Health Records (EHR) | Lung Cancer | Non-Small Cell Lung Cancer | Study